C000010843 Holdings — Putnam VT Global Health Care Fund
All 43 reported holdings of Putnam VT Global Health Care Fund (C000010843) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 10.75% | $15.19M |
| Johnson & Johnson | 9.17% | $12.96M |
| AbbVie, Inc. | 6.02% | $8.50M |
| Novartis AG | 5.23% | $7.40M |
| Merck & Co., Inc. | 4.94% | $6.98M |
| UnitedHealth Group, Inc. | 4.93% | $6.96M |
| AstraZeneca plc | 4.92% | $6.95M |
| Thermo Fisher Scientific, Inc. | 4.51% | $6.37M |
| Intuitive Surgical, Inc. | 4.06% | $5.73M |
| Sanofi SA | 3.58% | $5.06M |
| Putnam Short Term Investment Fund | 2.94% | $4.16M |
| Boston Scientific Corp. | 2.77% | $3.92M |
| Gilead Sciences, Inc. | 2.72% | $3.85M |
| Roche Holding AG | 2.64% | $3.72M |
| McKesson Corp. | 2.49% | $3.51M |
| Cardinal Health, Inc. | 2.26% | $3.19M |
| Vertex Pharmaceuticals, Inc. | 2.24% | $3.16M |
| Bristol-Myers Squibb Co. | 2.18% | $3.09M |
| CVS Health Corp. | 2.16% | $3.05M |
| Edwards Lifesciences Corp. | 2.05% | $2.90M |
| Ascendis Pharma A/S | 1.50% | $2.12M |
| HCA Healthcare, Inc. | 1.47% | $2.08M |
| Amgen, Inc. | 1.45% | $2.05M |
| Medtronic plc | 1.45% | $2.04M |
| Hoya Corp. | 1.30% | $1.84M |
| Ucb SA | 1.11% | $1.57M |
| Regeneron Pharmaceuticals, Inc. | 1.03% | $1.46M |
| Argenx SE | 1.01% | $1.43M |
| Insmed, Inc. | 1.00% | $1.41M |
| GSK plc | 0.96% | $1.35M |
| Chugai Pharmaceutical Co. Ltd. | 0.93% | $1.31M |
| Rhythm Pharmaceuticals, Inc. | 0.72% | $1.02M |
| United Therapeutics Corp. | 0.64% | $901.33K |
| Novo Nordisk A/S | 0.55% | $777.52K |
| Xenon Pharmaceuticals, Inc. | 0.54% | $755.95K |
| IQVIA Holdings, Inc. | 0.51% | $716.27K |
| Revolution Medicines, Inc. | 0.43% | $612.67K |
| Terns Pharmaceuticals, Inc. | 0.28% | $390.13K |
| Precigen, Inc. | 0.24% | $339.40K |
| United States of America | 0.14% | $197.89K |
| Euro | 0.00% | $353 |
| Australian Dollar | 0.00% | $172 |
| Danish Krone | 0.00% | $0 |
C000010843 overview: performance, fees, allocation and SEC filings